Follow us on Twitter
twitter icon@FreshPatents

Browse patents:
Next
Prev

Resolvins: biotemplates for novel therapeutic interventions / The Brigham And Women's Hospital, Inc.




Title: Resolvins: biotemplates for novel therapeutic interventions.
Abstract: The present invention is generally drawn to novel isolated therapeutic agents, termed resolving, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA), cyclooxygenase-II (COX-2) and an analgesic, such as aspirin (ASA). Surprisingly, careful isolation of compounds generated from the combination of components in an appropriate environment provide di- and tri-hydroxy EPA or DHA compounds having unique structural and physiological properties. The present invention therefore provides for many new useful therapeutic di- or tri-hydroxy derivatives of EPA or DHA (resolvins) that diminish, prevent, or eliminate inflammation or PMN migration, for example. The present invention also provides methods of use, methods of preparation, and packaged pharmaceuticals for use as medicaments for the compounds disclosed throughout the specification. ...


Browse recent The Brigham And Women's Hospital, Inc. patents


USPTO Applicaton #: #20100016432
Inventors: Charles N. Serhan



http://68.233.251.32/patentappdata/I20100121-xml/descriptions/20100016432-20100121.txt



[The Full Description and Claims for this patents is not available from FreshPatents.com temporarily]

We apologize for the inconvenience:
Normally the full description and claims of the patent you are viewing (20100016432, Resolvins: biotemplates for novel therapeutic interventions) would be available here (see sample below). However, this information from this patent is currently not available from our database.

Most likely, this is a temporary technical issue. We have logged this message and will attempt to resolve the issue. Please check back again soon.

sample

Advertise on FreshPatents.com - Rates & Info


You can also Monitor Keywords and Search for tracking patents relating to this Resolvins: biotemplates for novel therapeutic interventions patent application.

###


Browse recent The Brigham And Women's Hospital, Inc. patents

Keyword Monitor How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Resolvins: biotemplates for novel therapeutic interventions or other areas of interest.
###


Previous Patent Application:
Nerve-regenerating agent
Next Patent Application:
Inhibitors of egln3 activity for the treatment of neurodegenerative disorders
Industry Class:
Drug, bio-affecting and body treating compositions
Thank you for viewing the Resolvins: biotemplates for novel therapeutic interventions patent info.
- - -

Results in 0.00363 seconds


Other interesting Freshpatents.com categories:
Electronics: Semiconductor Audio Illumination Connectors Crypto

###

Data source: patent applications published in the public domain by the United States Patent and Trademark Office (USPTO). Information published here is for research/educational purposes only. FreshPatents is not affiliated with the USPTO, assignee companies, inventors, law firms or other assignees. Patent applications, documents and images may contain trademarks of the respective companies/authors. FreshPatents is not responsible for the accuracy, validity or otherwise contents of these public document patent application filings. When possible a complete PDF is provided, however, in some cases the presented document/images is an abstract or sampling of the full patent application for display purposes. FreshPatents.com Terms/Support
-121-0.1408

66.232.115.224
Browse patents:
Next
Prev

stats Patent Info
Application #
US 20100016432 A1
Publish Date
01/21/2010
Document #
File Date
12/31/1969
USPTO Class
Other USPTO Classes
International Class
/
Drawings
0


Aspirin Docosahexaenoic Acid Eicosapentaenoic Acid Polyunsaturated Fatty Acid

Follow us on Twitter
twitter icon@FreshPatents

The Brigham And Women's Hospital, Inc.


Browse recent The Brigham And Women's Hospital, Inc. patents



Drug, Bio-affecting And Body Treating Compositions   Designated Organic Active Ingredient Containing (doai)   Radical -xh Acid, Or Anhydride, Acid Halide Or Salt Thereof (x Is Chalcogen) Doai   Carboxylic Acid, Percarboxylic Acid, Or Salt Thereof (e.g., Peracetic Acid, Etc.)   Higher Fatty Acid Or Salt Thereof   Carbon To Carbon Unsaturation  

Browse patents:
Next
Prev
20100121|20100016432|resolvins: biotemplates for novel therapeutic interventions|The present invention is generally drawn to novel isolated therapeutic agents, termed resolving, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA), cyclooxygenase-II (COX-2) and an analgesic, such as aspirin (ASA). Surprisingly, careful isolation of compounds generated from |The-Brigham-And-Women-s-Hospital-Inc
';